Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article

Free Access

Factors Effecting Mastalgia

Eren T. · Aslan A. · Ozemir I.A. · Baysal H. · Sagiroglu J. · Ekinci O. · Alimoglu O.

Author affiliations

Department of General Surgery, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey

Corresponding Author

Tunc Eren, MD

Department of General Surgery

Istanbul Medeniyet University Goztepe Training and Research Hospital

Dr. Erkin Street, Goztepe, Kadikoy Istanbul, TURKEY

drtunceren@gmail.com

Related Articles for ""

Breast Care 2016;11:188-193

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Summary

Background: Breast pain is one of the leading complaints that ends up with referral to breast surgery clinics. The purpose of the present study was to investigate the factors that cause mastalgia, and its relation with benign or malignant breast disease. Methods: The study was performed in 700 patients. Data obtained from surveys, and imaging findings were prospectively recorded, and analyzed. Results: The mean age was 45.20 ± 10.78 years. The mastalgia group included 500 cases; the asymptomatic group comprised 200 individuals. Stressful lifestyle, caffeine consumption, and smoking were associated with mastalgia (p < 0.05). Rates of women who had breast fed 3 times or more were higher in the mastalgia group (p < 0.05). Increased breast density, and breast imaging-reporting and data system (BI-RADS) 2 mammography findings were related with mastalgia (p < 0.05). Cysts and fibroadenomas were more common in the mastalgia group (p < 0.05). The incidence of a past history of malignant breast disease was significantly higher in the mastalgia group (p < 0.05). Conclusions: Stress, caffeine, smoking, lactation frequency, and benign disorders were factors detected to be related with mastalgia. Although a significant relation between mastalgia and malignant breast disease was detected in our study, more controlled studies are still required to investigate this issue further.

© 2016 S. Karger GmbH, Freiburg


References

  1. Preece PE, Baum M, Mansel RE, et al.: Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) 1982;284:1299-1300.
  2. Ader DN, South-Paul J, Adera T, et al.: Cyclical mastalgia: Prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001;22:71-76.
  3. Morrow M: The evaluation of common breast problems. Am Fam Physician 2000;61:2371-2378.
    External Resources
  4. Goyal A, Mansel RE: Mastalgia; in Jatoi I, Kaufmann M (eds): Management of breast disease. Springer-Verlag, Berlin, 2010, pp. 69-76.
    External Resources
  5. Schorge J: Breast disease; in Schorge J, Schaffer J, Halvorson L, et al. (eds): Williams Gynecology, 1st ed. McGraw-Hill Medical, New York, NY, 2008, pp. 269-290.
  6. Smith RL, Pruthi S, Fitzpatrick LA: Evaluation and management of breast pain. Mayo Clin Proc 2004;79:353-372.
  7. Salzman B, Fleegle S, Tully AS: Common breast problems. Am Fam Physician 2012;86:343-349.
    External Resources
  8. Iddon J: Mastalgia; in Dixon JM (ed): ABC of breast disease, 3rd ed. Blackwell Publishing, Edinburgh, UK, 2006, pp. 15-18.
  9. Leung JW, Korguth PJ, Gotway MB: Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 2002;21:521-526.
    External Resources
  10. Barton MB, Elmore JG, Fletcher SW: Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med 1999;130:651-657.
  11. Lumachi F, Ermani M, Brandes AA, et al.: Breast complaints and risk of breast cancer. Population-based study of 2879 self-selected women and long-term follow-up. Biomed Pharmacother 2002;56:88-92.
  12. Fariselli G, Lepera P, Viganotti G, et al.: Localized mastalgia as presenting symptom in breast cancer. Eur J Surg Oncol 1988;14:213-215.
    External Resources
  13. Smallwood JA, Kye DA, Taylor I: Mastalgia; is this commonly associated with operable breast cancer? Ann R Coll Surg Engl 1986;68:262-263.
    External Resources
  14. Johnson KM, Bradley KA, Bush K, et al.: Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes. J Gen Intern Med 2006;21(Suppl 3):S70-75.
  15. Preece PE, Mansel RE, Hughes LE: Mastalgia: Psychoneurosis or organic disease? Br Med J 1978;1:29-30.
  16. Jenkins PL, Januil N, Gateley C, et al.: Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psychiatry 1993;15:55-57.
  17. Colegrave S, Holcombe C, Salmon P: Psychological characteristics of women presenting with breast pain. J Psychosom Res 2001;50:303-307.
  18. Tejwani PL, Srivastava A, Nerkar H, et al.: Centchroman regresses mastalgia: A randomized comparison with danazol. Indian J Surg 2011;73:199-205.
  19. Rose DP, Boyar AP, Cohen C, et al.: Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. J Natl Cancer Inst 1987;78:623-626.
    External Resources
  20. Wang DY, Fentiman IS: Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 1985;6:5-36.
  21. Wisbey JR, Kumar S, Mansel RE, et al.: Natural history of breast pain. Lancet 1983;2:672-674.
  22. Tavaf-Motamen H, Ader DN, Browne MW, et al.: Clinical evaluation of mastalgia. Arch Surg 1998;133:211-214.
  23. Plu-Bureau G, Le MG, Sitruk-Ware R, et al.: Cyclical mastalgia and breast cancer risk: Results of a French cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:1229-1231.
  24. Hernanz F, Santos R, Arruabarrena A, et al.: Treatment of symptomatic macromastia in a breast unit. World J Surg Oncol 2010;8:93.
  25. Degeorge BR Jr, Colen DL, Mericli AF, et al.: Reduction mammoplasty operative techniques for improved outcomes in the treatment of gigantomastia. Eplasty 2013;13:e54.
    External Resources
  26. Salgado CJ, Mardini S, Chen HC: Mastodynia refractory to medical therapy: Is there a role for mastectomy and breast reconstruction? Plast Reconstr Surg 2005;116:978-985.
  27. Santen RJ, Mansel R: Benign breast disorders. N Engl J Med 2005;353:275-285.
  28. Kizilkaya MC, Erozgen F, Kocakusak A, et al.: Mastalgia in daily practice. J Breast Health 2013;9:191-194.
  29. Srivastava A, Mansel RE, Arvind N, et al.: Evidence-based management of mastalgia: A meta-analysis of randomised trials. Breast 2007;16:503-512.
  30. Colak T, Ipek T, Kanik A, et al.: Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003;196:525-530.
  31. Kumar S, Rai R, Agarwal GG, et al.: A randomized, double-blind, placebo-controlled trial of ormeloxifene in breast pain and nodularity. Natl Med J India 2013;26:69-74.
    External Resources
  32. Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, et al.: Breast pain and mammographic density increase as a consequence of raloxifene therapy. J Endocrinol Invest 2002;25:564-566.
  33. Khanna AK, Tapodar J, Misra MK: Spectrum of benign breast disorders in a university hospital. J Indian Med Assoc 1997;95:5-8.
    External Resources
  34. Yuksekkaya R, Celikyay F, Voyvoda N, et al.: Breast ultrasound findings in patients with mastalgia under the age of fourty. J Breast Health 2012;8:19-22.
  35. Goodwin PJ, DeBoer G, Clark RM, et al.: Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat 1995;33:63-73.
  36. Plu-Bureau TJC, Sitruk-Ware R, Asselain B, et al.: Cyclical mastalgia as a marker of breast cancer susceptibility: Results of a case-control study among French women. Br J Cancer 1992;65:945-949.
  37. Khan SA, Apkarian AV: Mastalgia and breast cancer: A protective association? Cancer Detect Prev 2002;26:192-196.

Article / Publication Details

First-Page Preview
Abstract of Original Article

Published online: March 29, 2016
Issue release date: June 2016

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 5

ISSN: 1661-3791 (Print)
eISSN: 1661-3805 (Online)

For additional information: https://www.karger.com/BRC


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.